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The collection of IR spectra through microscope optics and the visualization of the IR data by IR imaging represent a visualization approach, which
uses infrared spectral features as a native intrinsic contrast mechanism. To illustrate the potential of this spectroscopic methodology in breast cancer
research, we have acquired IR-microspectroscopic data from benign and malignant lesions in breast tissue sections by point microscopy with spot sizes
of 30–40 μm. Four classes of distinct breast tissue spectra were defined and stored in the data base: fibroadenoma (a total of 1175 spectra from 14
patients), ductal carcinoma in situ (a total of 1349 spectra from 8 patients), connective tissue (a total of 464 spectra), and adipose tissue (a total of 146
spectra). Artifical neural network analysis, a supervised pattern recognition method, was used to develop an automated classifier to separate the four
classes. After training the artifical neural network classifier, infrared spectra of independent external validation data sets (“unknown spectra”) were
analyzed. In this way, all spectra (a total of 386) taken frommicro areas inside the epithelium of fibroadenomas from 4 patients were correctly classified.
Out of the 421 spectra taken frommicro areas of the in situ component of invasive ductal carcinomas of 3 patients, 93%were correctly identified. Based
on these results, the potential of the IR-microspectroscopic approach for diagnosing breast tissue lesions is discussed.
© 2006 Elsevier B.V. All rights reserved.Keywords: Infrared microspectroscopy; Infrared imaging; Artifical neural network; Breast cancer; Cancer diagnostic1. Introduction
Traditionally, the diagnosis of breast tumors is based on visual
inspection of stained tissue sections by an experienced patholo-
gist. The standard histopathological procedures have in common
that they “tag” and visualize the distribution and structure of
cellular components in tissue sections using standard light mi-
croscopy-based techniques. Infrared microspectroscopy is a re-
latively new tool for examining tissue sections, which requires
neither sample staining nor fixation [1–5]. In combination with
advanced data processing techniques, this new approach has the
potential to complement established strategies of tissue section
diagnosis [3–6]. In a conventional IR imaging system the spectra
are collected using an IR microspectrometer with a globar as IR-⁎ Corresponding author. Fax: +49 30 45472606.
E-mail address: fabianh@rki.de (H. Fabian).
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.05.015light source and a single-point detector element. Point-by-point
mapping experiments of tissue sections have proved that the IR
approach enables the segmentation of major tissue structures
based on their IR spectra and the diagnosing of pathologic tissue
alterations [6–11]. However, the collection of individual spectra
over large areas of tissue is very time consuming (hours) and the
spatial resolution is limited because of the low throughput of IR
light through small apertures sizes (20–30 μm). The situation
improved considerably by a new generation of IR microspect-
rometers in which the optical aperture is omitted and the single-
element detector is replaced by a multi detector array [5]. The
latter approach enables to sample larger tissue areas very rapidly
(in minutes) and at a spatial resolution of 5–10 μm,which is at the
diffraction limit in the mid-IR region.
In themid-1990s, we have carried out IR-spectroscopy and IR-
microscopy studies on human breast tumors, xenografted breast
tumors, and breast tumor cell lines, which demonstrated the im-
portance of correct sampling and knowledge of sample histology
875H. Fabian et al. / Biochimica et Biophysica Acta 1758 (2006) 874–882in order to avoid incorrect interpretation of spectral differences
[7,12]. For example, differences on a microscopic level between
adjacent small areas (30 μm2) of xenografted tumors (trans-
planted tumors grown in nude mice) have been detected, which
could be attributed to local variations in the collagen content [7].
The data suggested that previously reported spectral changes
observed by others between malignant and normal tissues, which
were attributed to structural changes in DNA, may have an
alternative explanation, and may in fact be due to variations in
connective tissue content on a microscopic level. Moreover,
comparative studies of human breast tumor cell lines demon-
strated that related cell types can be differentiated based on their
infrared spectra [12]. The studies suggested that infrared methods
may have the potential to differentiate not only between major
tissue constituents present in breast tissue but also, e.g., between
malignant and benign breast tumors.
Recently, we have applied mid-IR microspectroscopic imag-
ing to malignant breast tumor tissue sections [13]. Most types of
breast cancer start in the linings of the ducts and lobules of the
breast. Typically, cancer-related changes in the breast involve
only subtle alterations in the biochemical and morphological
composition of the tissue. Moreover, these changes occur at the
microscopic level. This requires to collect high-quality spectra
and to examine tissue sections with high spatial resolution. As
illustrated in our previous paper, breast tissue microheterogeneity
is a particularly severe problem for IR microspectroscopy in case
of invasive ductal carcinomas. An invasive carcinoma is the
progressively destructive phase where the tumor invades the
surrounding breast tissue. This implies the need for collecting IR
spectra at the level of individual cells to minimize the possibility
of “contamination” of the spectra. This “contamination” problem
was found to be much less severe in case of the ductal carcinoma
in situ. A ductal carcinoma in situ (DCIS) represents the
beginning stage of tumor development. TheDCIS is characterized
by neoplastic cell proliferation inside the breast ducts, whereas the
organoid structure remains preserved. Another breast lesion,
which is also located in the ducts, is a fibroadenoma. Fibro-
adenoma is a benign tumor, which is very common and, fortu-
nately, does not tend to become malignant. As a very first step in
the evaluation of the diagnostic power of IR-microspectroscopy,
we have recently compared the IR spectral characteristics of a
fibroadenoma and of a malignant tumor (DCIS) [14]. Our own
initial data suggested that the two breast tumor types can be
differentiated based on their IR spectra. The work presented here
on an extended pool of breast tumor tissue samples applies auto-
mated classification methods in order to evaluate the diagnostic
potential of the IR approach.
2. Materials and methods
2.1. Tissue preparation
Human breast tumor tissue was obtained from the tumor bank of the Robert-
Rössle-Clinic of Oncology, Humboldt-University, Charité, in Berlin-Buch. For
sectioning the tissue blocks were water-mounted on a cryostat table at a tem-
perature of −27 °C. Serial cryo-sectioning was performed at a pre-defined
thickness of 7 μm. Slices were either thaw-mounted on 1 mm thick CaF2 or BaF2
windows for IR microscopy or were mounted on conventional glass slides forstaining with hematoxylin and eosin for light microscopy. Regions of interest were
identified using the hematoxylin and eosin (H&E) stained sections under a light
microscope (Olympus BX50). Corresponding patterns on the unstained tissue
mounted on CaF2 or BaF2 windows were identified utilizing the native and the
Nomarski contrast mode, respectively.
2.2. Data acquisition
Conventional point-by-point mapping experiments in transmission mode were
performed on two experimental set-ups, each consisting of a Bruker A 590 IR
microscope attached to aBruker IFS28BFourier transform IR spectrometer. The IR
microscopes were isolated in a vented Plexiglas housing to enable purgingwith dry
air in order to reduce spectral contributions from atmospheric water vapour and
CO2. Selected areas of interest were mapped with aperture diameters of 30 or
40 μm. Typically, spectra at a spectral resolution of 6 cm−1 were generated
from 70 interferograms collected at each position.
Selected IR imaging experiments were performed in the application labs of
Bruker-Optik GmbH in Ettlingen, Germany and of Perkin-Elmer in Seer Green,
UK. The Bruker Hyperion IR imaging system was composed of a Bruker IFS-66
step-scan Fourier transform spectrometer coupled to a Bruker IRScope II IR
microscope equipped with a 64×64 MCT focal plane array detector, as described
previously [13,14]. Data were acquired in transmission mode from areas of 260 by
260 μm mapped to the individual elements of the array detector, resulting in 4096
individual pixel spectra. The spectral resolution was set to 6 cm−1.
At Perkin-Elmer, the data were collected using the Perkin-Elmer Spotlight 300
IR microscope equipped with a 16-element linear array detector and a computer-
controlled sample stage. Data were acquired in transmission mode and the sample
was raster scanned to access an area of 1100 μm×1060 μm. The spectral resolution
was set to 8 cm−1 and the acquisition time was approximately 50 minutes.
2.3. Data pre-processing and analysis
2.3.1. Cluster analysis
The data were analyzed using routines of the CytoSpec IR imaging software
(www.cytospec.com). Pre-processing of the rough data included a quality test to
exclude single spectra of very low intensities. Such spectra, e.g., due to tissue
gaps, were routinely excluded from further analysis. Spectra passing the test
were subsequently vector normalized between 1000 and 1900 cm−1. Cluster
analysis was performed on first derivative spectra (9-point Savitzky–Golay
algorithm). Spectral distances were calculated as so-called D-values (redefined
Persons correlation coefficients) and the Ward's algorithm was used for hierar-
chical clustering [11].
2.3.2. Artifical neural network analysis
Data pre-processing, network training, and classification was performed using
Synthon's NeuroDeveloper software package specifically designed for ANN
analysis of infrared spectral data. Data pre-processing included calculation of first
derivatives (Savitzky–Golay algorithm, 5-point smoothing) and averaging two
adjacent data points. Artifical neural network calculations were performed based
on a three-layer feedforward networkwith the Rprop learning function[15]. For the
analysis, the spectral data (1st derivatives)were split into a training data set (used to
estimate the network model parameters), an internal validation data set (used to
check the generalization ability of the network), and an external validation data set.
The external validation data set can be considered as the best and strictest estimator
for the generalization ability of the ANN-model. The high degree of spectral
information redundancy over the entire spectral regionwas diminished by a feature
selection algorithm. This improved the quality of the classifier considerably and
reduced the complexity and dimensionality of the classification model.
3. Results and discussion
3.1. Imaging of benign breast tumor tissue sections
Fig. 1A shows the H&E stained section of a breast fibro-
adenoma. Three major tissue components are discernable:
(I) ductal epithelium, (II)mantle tissue and (III) distant connective
Fig. 1. Images of 7 μm thin cryo-sections of a human breast fibroadenoma. (A) Photomicrograph of a H&E stained tissue section showing three major tissue
constituents: benign duct (I), mantle zone (II), and distant connective tissue (III). Magnification: ×100. (B) Photomicrograph of the corresponding serial section
mounted on a BaF2 window differentially interference contrasted according to the Nomarski technique (magnification: ×100). The dashed black lines embrace the two
areas selected for IR examination. (C) IR image of the fibroadenoma section based on the results of cluster analysis using 2×4096 single pixel spectra obtained with an
array detector system at a spatial resolution of 6–10 μm. Each block represents a spectrum acquired at this position. Pixels of the same color indicate that the spectra at
these positions fall within the same cluster. Cluster analysis was performed by utilizing the spectral information in the regions 1000–1500 cm−1 and 2800–3000 cm−1.
(D) IR image of the fibroadenoma based on cluster analysis using 26×13 point-by-point spectral data obtained at a spatial resolution of 30 μm.
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adjacent nonstained serial section used for IR analysis. Clear
architectural features of the tissue for survey purposes remain
visible. This includes the sharp marked ductal outline at the site of
the basement membrane as one criterion for structural organiza-
tion. The areas inside the two dashed black outline squares were
examined via an IR microscope equipped with a Bruker focal
plane array detector system.
IR spectral images preserves histo-morphological aspects
from the light microscopy image. In addition, the IR approach
enables the detection and quantification of the molecular bio-
chemistry of microscopic samples, thus opening up a new dimen-
sion in the analysis of tissue sections. Several methods can be
used to convert IR multispectral data into a two-dimensional
image. A frequently used approach is known as functional group
intensity or frequency shift mapping [3,4]. This procedure results
in a chemically specific contrast of tissue sections, which easily
permits the identification and visualization of a number of major
tissue constituents, such as collagen, fat or cellular components.More sophisticated approaches, such as unsupervised cluster
analysis, are now becoming routine. Cluster analysis groups
spectra based upon the degree of similarity between spectra.
Spectra (objects) that are similar to each other appear in one group
(cluster) and spectra being different are grouped into different
clusters. In this way, areas of tissue exhibiting similar biochem-
istry can be identified. For cluster imaging, the class membership
is color encoded and plotted as a function of the x,y-coordinates
within the tissue section [11].
By comparison of the IR image of the fibroadenoma tissue
section based on the results of hierarchical cluster analysis of the
2×4096 single pixel spectra (Fig. 1C) with the H&E photomi-
crograph of the tissue section (Fig. 1A), the red colored regions
can be assigned as the nuclear rich epithelial proliferation of the
previously diagnosed breast fibroadenoma. The yellow area in-
termixed with some blue pixels as seen in Fig. 1C belongs to the
mantle zone. The surrounding blue area represents distant con-
nective tissue. The presence of some related red colored pixels
within the right circumference of the yellow colored mantle zone
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[14]. The latter feature cannot be detected by classical point IR
microspectroscopy, where the spatial resolution is limited to
∼20 μm or more (Fig. 1D). Individual breast tumor cells are only
approximately 10 μm in diameter and, thus, the spectrum ob-
tained from a microarea of ∼30 μm in diameter is always the
composite spectrum of the tumor cells themselves and other
components surrounding the cells. This spectral “averaging”
problem of all tissue components present in corresponding micro
areas ismuch less severe if the tumor cells are tightly packed, such
as in the nuclear rich breast duct epithelia. If one concentrates on
these micro areas of a breast tissue section, then it is feasible to
minimize the possibility of “contamination” of the spectra even
when applying the classical point microspectroscopy approach.
3.2. IR spectra of major tissue constituents of benign breast
tumor tissue sections
Fig. 2 shows representative IR spectra of major tissue cons-
tituents present in fibroadenoma tissue sections obtained by point
microspectroscopy.Many of the IR spectral features of breast duct
epithelia, connective tissue, and adipose tissue have been pre-
viously assigned to defined functional groups of proteins, nucleic
acids, and lipids that make up the respective tissue [7–11].
Features between 1500 and 1700 cm−1, assigned to the amide I
and amide II bands of proteins, dominate the spectra of tumor cells
and connective tissue. The most intense band near 1655 cm−1
(amide I) arises primarily from the C_O stretching vibrations of
the amide groups of the protein backbone, while the absorption
band near 1542 cm−1 (amide II) arises from amide N–H bending
vibrations. The spectral characteristics of both bands are known toFig. 2. IR spectra of major tissue constituents observed within benign breast tumor ti
diameter: (A) absorbance spectra of the epithelium of a fibroadenoma, (B) connectibe sensitive to protein backbone conformation [16,17]. The broad
feature centred between 3290 and 3320 cm−1 is due to protein NH
stretching vibrations. In connective tissue, the region between
1000 and 1340 cm−1 is dominated by absorptions from collagen
(e.g., at 1033, 1082, 1234 and 1336 cm−1), arising from C–OH
stretching vibrations of collagen carbohydrate moieties, C–N
stretching vibrations of the collagen backbone and CH2 wagging
vibrations of collagen side chains [7]. Nucleic acids give rise to
absorptions of medium intensity between 1220–1240 cm−1 and
at 1083 cm−1, arising from PO2
− asymmetric and symmetric
stretching vibrations, respectively [18]. Less intense absorptions
attributed to in-plane double-bond vibrations of the bases occur
between 1720 and 1630 cm−1. Lipids give rise to a number of
absorptions in IR spectra. The most intense of these absorptions
are found in the range 2800–3000 cm−1 and are assigned to
asymmetric and symmetric stretching vibrations of CH2 (near
2924 and 2853 cm−1) and CH3 (near 2959 and 2873 cm
−1)
groups of the acyl chains. The positions and widths of the CH2
and CH3 absorptions provide information regarding the packing
characteristics of the acyl chains, which in turn may be related to
the fluidity of cell membranes [19]. Absorptions also arise from
the headgroup and the interfacial region of lipids, including
absorptions attributed to ester C_O stretching vibrations
(1746 cm−1), PO2
− asymmetric (1238 cm−1), and symmetric
(1080 cm−1) stretching vibrations. In isolated phospholipid
systems, the ester C_O stretching and PO2
− stretching vibrations
result in absorptions of approximately equal intensity. The low
intensity of the ester C_O absorption in Fig. 2A indicates that
lipid-like materials contribute little intensity to fibroadenoma cell
spectra. Further major absorptions in the spectra of lipids arise
from CH2 bending (1463 cm
−1) and ester CO–O–C stretchingssue sections acquired through a microscope that sampled an area of ~30 μm in
ve tissue, (C) adipose tissue, and (D) milk secretion in ducts.
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which has been discussed previously [14], is milk secretion fluid.
Its spectrum (Fig. 2D) differs in some spectral regions (e.g.,
between 1000 and 1200 cm−1) from the spectrum of adipose
tissue (Fig. 2C). The very intense CH2 and CH3 absorptions of
milk secretion fluid are not shown for brevity.
3.3. Collection of point spectra from benign and malignant
breast lesions
A comparison with the FPA spectra revealed that, on the
average, the signal-to-noise ratio of the point spectra from dif-
ferent tissue constituents was 5–10 times higher than those of the
single pixel spectra obtained by the focal plane array system.
Similar results have been obtained for DCIS tissue sections [13].
Different breast tumor types are known to express only subtle
differences in the intrinsic biochemical composition and organi-
zation of the corresponding tissue. As a consequence, only minor
spectroscopic differences between different tumor types can be
expected. Although the conventional pointmapping approach can
fail to detect small numbers of tumor cells owing its low spatial
resolution capabilities, it offers the possibility to acquire high-
quality spectra. This prompted us to test whether fibroadenoma
and ductal carcinoma in situ can be differentiated based on their
IR point spectra. For this purpose, tissue sections from 22 patients
were examined by using IR microspectroscopy. Being aware of
problems associated with microheterogeneity of tissues, only
spectra of well-defined tumor areas were pre-selected for this
study. After the point-by-point mapping experiments, each
mapping data set was evaluated by cluster analysis first. By
comparing the cluster image with the H&E-stained photomicro-
graph of the corresponding tissue section, areas characteristic of
major tissue components were identified. Spectra characteristic of
the corresponding cluster (tissue component) were selected by a
routine of the CytoSpec software and stored. Spectral data that
could suffer from a spectral “averaging” problem associated with
different tissue components present in the corresponding micro-
areas, such as the spectra of the mantle zone of the fibroadenoma
shown in Fig. 1D (yellow area), were excluded from further
analysis.
3.4. Differentiation between fibroadenoma and ductal carci-
noma in situ
Four classes of distinct breast tissue spectra were defined and
stored in the data base: spectra from fibroadenoma (FA), ductal
carcinoma in situ (DCIS), connective tissue (a total of 464 spec-
tra), and adipose tissue (a total of 146 spectra). Artifical neural
network (ANN) analysis, a supervised pattern recognition me-
thod, was used to develop an automated classifier to separate the
four classes. Supervisedmethods make use of the fact that clinical
information concerning the samples from which the spectra were
obtained is available. This information is used to train the clas-
sifier in order to predict the class identity of unknown spectra
afterwards. The quality of the training process can be assessed on-
line by classifying data of a so-called internal validation subset.
The spectra of those data sets are not used for teaching but arecontinuously analyzed during teaching. When the teaching pro-
cess is finished, the classifier is challenged by a third independent
data set for external validation. It is important to note that this
latter subset of spectra (“unknown spectra”) is kept totally
separate form the training and internal validation procedure. The
benign tumor spectra from 4 patients (a total of 386 spectra) and
themalignant tumor spectra from3 patients (a total of 421 spectra)
were selected for testing the classifier performance (external
validation). All the remaining reference spectra of the data base
(631 spectra from 10 patients with FA, 743 spectra from 5 patients
with DCIS) were combined in a network training and a network
internal validation set, respectively. Half of the spectra of con-
nective tissue and fat, respectively, were selected for training. The
second half of the data set was splitted into spectra selected for
internal and external validation, respectively. Two spectral win-
dows were chosen for network analysis: (i) The range 900–
1500 cm−1 alone (region 1), and (ii) region 1 in combination with
range 2800–3100 cm−1. Region 1 was chosen because our
previous analysis of a limited data set indicated that the two breast
tumor types can be differentiated based on their IR spectra in this
spectral range [14].
A combined ANN analysis of the data set containing all 4
classes of breast tissue revealed that all spectra of connective
tissue and adipose tissue were classified correctly (data not
shown). This is not surprising because their spectral features are
clearly different from each other and from those of tumors as well
(see Fig. 2). While all tumor spectra used for internal validation
were classified correctly as fibroadenoma or DCIS in accordance
with the histopathological examination, some problems arised
during external validation. The test of the established ANNmodel
with independent fibroadenoma spectra resulted in a correct
classification of all FA spectra, but only 85% of the DCIS spectra
of the test data set were correctly classified. This was not sur-
prising, because different breast tumor types are known to express
only subtle differences in the intrinsic biochemical composition
and organization of the corresponding tissue. As a consequence,
only minor spectroscopic differences between the two tumor
types can be expected. In such cases, a toplevel/sublevel strategy
for ANN analysis of the data set turned out to be useful [15]. On
the toplevel, only spectra representing 3 classes of tissue (in the
present case connective tissue, adipose tissue, and fibroadenoma
plus DCIS) were analyzed. After training and internal validation
of the toplevel net, all 3 classes of spectra were classified cor-
rectly. Afterwards, a sublevel data set representing only fibro-
adenoma and DCIS spectra was generated. During training of the
subnet, the algorithm is now only searching for spectral features
that permit to differentiate between the two tumor types.
The spectral information of the two classes discriminating
DCIS and FA in the sublevel network was extracted by trans-
forming the training dataset into principal components. Principal
Component Analysis (PCA) is a statistical method used for the
extraction of a set of uncorrelated variables which explain most of
the variance in the dataset. The method comprises most of the
information of the dataset within those variables (called principal
components) and thus, can be used for data compression and
unsupervised feature extraction tasks [15]. In our case, PCA of the
training spectra representingDCIS and FA resulted in 45 principal
Table 1
Classification results of neural network analysis of breast tumor spectra
Tissue Training Internal
validation
External validation
900–1500 and 2800–3100
cm−1
900–1500
cm−1
FA 631 158 (158) 386 (386) 386 (380)
DCIS 743 185 (185) 421 (391) 421 (384)
The numbers represent the total number of spectra used for training, internal
validation, and external validation of the network. The numbers in parentheses are
the spectra classified by ANN analysis in accordance with the histopathological
classification of the corresponding tumor. FA=fibroadenoma, DCIS=ductal
carcinoma in situ. Note that the spectra of the external validation data set were not
included into the training/internal validation process.
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computed principal components cannot be interpreted easily due
to their nature as linear combinations of the original values, their
information content regarding the separability of “DCIS” from
“FA” is higher those of the original data. Subsequent ANN
training was performed on the generated principal components
using resilient backpropagation as learning function [13]. Al-
though principal components greater than 10 may contain very
little spectral information, automated search for optimal neural
network topology revealed that a feed-forward network using
finally a subset of 26 principal components as input neurons, 20
units in the hidden layer and 2 output units with the class
assignments “DCIS” and “FA” performed best.
Based on the toplevel/sublevel strategy, all of the fibroade-
noma spectra and 93% of the DCIS spectra were correctly clas-Fig. 3. (A) Mean IR spectra of breast ducts representative of the epithelium of a f
carcinoma (solid line). The spectra are shown after vector normalization in the range
FA spectrum). Note that the absorbance scale for the difference spectrum in part Bsified (Table 1). This result was obtained by analyzing the spectral
information contained in both, the range 900–1500 cm−1 and in
the CH stretching region (2800–3100 cm−1). The accuracy of
classification of fibroadenoma was slightly reduced when the
latter region was omitted from data analysis (right column in
Table 1), suggesting that lipid-like spectral features might be
important for classification. It is interesting to note that practically
all the misclassified point spectra of DCIS were members of the
spectral data set acquired from a single tissue section (29 out of
220 spectra). This suggests that the small number of misclassified
spectra may represent an intrinsic variability of the corresponding
section, rather than a weakness of the established ANN classifier.
To get possible insights into the global chemical changes
associated with the two breast lesions, we have compared the
mean IR spectra of fibroadenoma and of ductal carcinoma in situ
(Fig. 3A). The majority of the spectral features of the difference
spectrum (at 1173, 1380, 1466, 2852 and 2923 cm−1 in Fig. 3B)
correlates with major absorption bands of fat (Fig. 1C). This
suggests that the microareas diagnosed as DCIS have more lipid-
like material than those diagnosed as fibroadenoma. As discussed
previously, only spectra of well-defined tumor areas have been
preselected for this comparative study. Thus, it seems unlikely
that the higher content of fat-like features observed in the DCIS
spectra is simply a consequence of the spectral “averaging”
problem associated with the collection of point spectra from mi-
croareas of 30–40 μm in diameter. This suggestion was
corroborated by a comparative analysis of the FPA single pixel
spectra acquired from the fibroadenoma shown in Fig. 1 and a
DCIS [13] (data not shown). Although the signal-to-noise ratio ofibroadenoma (dashed line) and of the in situ component of an invasive ductal
1800–900 cm−1. (B) IR difference spectrum (mean DCIS spectrum minus mean
was expanded by a factor of 4 compared to the scale in part A.
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nitude lower than those of the spectra obtained by point-by-point
mapping, the mean FPA spectra also revealed a higher content of
fat-like features in DCIS. In order to test whether fat-like IR
spectral features alone permit to differentiate DCIS and FA, we
have trained anANNclassifier using only the spectral information
contained in the range 2800–3100 cm−1. The external validation
with independent DCIS spectra revealed that almost half of the
DCIS spectra were misclassified. This demonstrates that a
complex pattern of features across a wide spectral range (900–
1500 cm−1 in combination with 2800–3100 cm−1), rather than
specific fat-like features alone, are necessary for differentiation of
fibroadenoma from ductal carcinoma in situ.
During our research, we have also examined tissue sections
diagnosed as invasive ductal carcinomas (IDC). An invasive
carcinoma is the phase where the tumor infiltrates in between
surrounding breast tissue, which is often made up by adipose
tissue. An inspection of the IR spectra acquired by classical point
microspectroscopy not seldomly revealed large differences from
spectrum to spectrum, which could be correlated with variations
in the amount of fat present in the corresponding microareas. ThisFig. 4. Images of a breast tissue section containing a ductal carcinoma in situ. (
photomicrograph of the H&E stained adjacent section of the specimen. The red line
generated by using four clusters. (C) IR image of clustering results generated by us
intensity values (red, high; blue, low) were taken from the absorbance spectra after no
Individual spectra with very low absorbance values are indicated by black spots.suggests that the data set of individual point spectra of sections
diagnosed as IDC might not adequately represent the “pure” IR
features of IDC. A spectrum obtained from a spot of ∼30 μm in
diameter is always the composite spectrum of individual breast
tumor cells themselves and of other components surrounding the
cells. If the cells are not as tightly packed as in nuclear rich breast
ducts, the tumor cell signal may be overwhelmed by the spectral
contributions of other components surrounding the cells, which
may vary from spot to spot. Spectral differences among individual
data sets unrelated to the disease state may cause the classifier to
behave unpredictably and, thus, the point spectra acquired from
IDC sections could not be used for ANN analysis. While classical
point IR microspectroscopy is a useful practical approach for
examination of lesions located in breast ducts, IR imaging ap-
proaches offering higher spatial resolution seems to bemandatory
for the characterization of invasive breast lesions.
Some state-of-the-art IR imaging instruments now permit to
collect single pixel spectra with high spectral quality and low
pixel-to-pixel variability [20]. The spatial resolution of the instru-
ments is determined by the optical configuration of the system,
which is usually set to 5–10 μm. As an example, recently we hadA) Visible image of a cryosection of unstained breast tissue, overlayed by a
defines the area selected for IR examination. (B) IR image of clustering results
ing six clusters. (D) IR image based on IR band intensities at 1080 cm−1. The
rmalization with respect to the integrated intensity between 1000 and 1900 cm−1.
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sections using a Perkin-Elmer Spotlight 300 system. The sample
was raster scanned over an area of 1.10×1.06 mm2. Each pixel
sampled of an area of 6.25×6.25 μm at the sample plane. Fig. 4A
shows a visible image of a cryosection of unstained breast tissue,
overlayed by a photomicrograph of the H&E stained adjacent
section of the specimen. The H&E image reveals a ductal car-
cinoma in situ (stained in purple) in the center and on the upper
side, surrounded by connective tissue (stained in pink). Colorless
areas point to fat or tissue gaps. The red line indicates the area
selected for IR examination. Cluster analysis of the 29920 single
pixel spectra permitted identification of four major clusters of
spectra. Fig. 4B displays an IR image based on cluster analysis of
the 176×170 single pixel spectra. Spectra of the DCIS are color
encoded by red,while the blue regions correspond to collagen rich
connective tissue. Spots dominated by fat are shown in white
(lower right corner). Comparison of the cluster image with the
histological data reveals that the yellow color encodes single pixel
spectra which arise primarily from spots at the borderline between
tumor and connective tissue. Thus, the four major clusters of
spectra represent specific tissue structures of the section.
The clustering process is unsupervised (i.e. objective), but the
definition of the number of clusters is a subjective step in this
procedure, and may become more and more ambiguous in terms
of known histopathology. However, images generated by super-
imposing an increasing number of single color cluster images
permits one to identify whether there are differences between
spectra belonging to a major clusters. In case of the studied DCIS
section, maps obtained for 5 (not shown) and 6 clusters (Fig. 4C)
only revealed some substructures in the borderline regions bet-
ween tumor and connective tissue, while the tumor regions itself
were encoded by the same color. The latter result shows that the
single pixel spectra of the tissue regions diagnosed as DCIS are
practically identical. In other words, no tissue substructures with-
in the tumor regions could be detected at a spatial resolution of 6–
7 μm. This corroborates our previous study [14], which suggested
that point microscopy with spot sizes of 20–40 μm may be a
useful practical approach for acquiring IR spectra of assemblies of
tumor cells in breast ducts.
A procedure, which easily permits the identification and vis-
ualization of major tissue constituents, is functional group inten-
sitymapping. For example, the contrast image shown in Fig. 4D is
based on IR band intensities at 1080 cm−1, which are known to be
primarily characteristic of nuclear material (DNA, RNA). The
locations, sizes, and shapes of the red colored areas in Fig. 4D are
in good accordance with the H&E stained tumor areas shown in
Fig. 4A. Thus, plotting the intensity at around 1080 cm−1 as a
function of the x,y-coordinates within the tissue section is an easy
and fast way for discriminating nuclear material from connective
tissue. The specific spectroscopic image contrast, arising from the
inherent chemical composition of the tissue rather than from
extrinsic reagents, offers some interesting possibilities for bio-
analytical applications. For example, laser micro-dissection tech-
niques are established methodologies to remove nuclear-rich
material from tissue sections. In order to identify the locations of
the nuclear-rich areas, typically conventional staining procedures
have to be applied. In future, a combination of IR imaging tech-niques with laser micro-dissection technologies might provide a
novel means of identifying micro areas of interest without the
need for tissue staining.
4. Conclusions
The present study demonstrates that benign and malignant
lesions in breast tumor tissue sections, such as fibroadenoma and
ductal carcinoma in situ, can be differentiated based on their IR
spectra. Despite only small differences between the spectra of the
two lesions, artifical neural networks strategies were able to
recognize spectral features that permitted us to develop an auto-
mated classifier to separate fibroadenomas from ductal carcino-
mas in situ. The classification was based on a complex pattern of
features across a wide spectral range. This argues against the
concept that the simple analysis of distinct spectral markers, such
as suggested by other authors [21] could serve for the differ-
entiation of benign from malignant breast tissue. Moreover, this
work provides further insights into problems associated with the
variability of the samples on amicroscopic level. For instance, the
spectral “averaging” problem prevented us from obtaining “pure”
spectra of invasive ductal carcinomas, evenwhen the spectra were
acquired using aperture diameters of only 30–40 μm. Thus,
although promising, the present study represents only a first step
in the evaluation of the diagnostic power of the IR approach. A
significantly extended data base of spectra of histopathologically
well-defined tissues, which spans the natural variability of healthy
and tumor breast tissues, is required in order to fully explore the
possibilities of IR microspectroscopy. Here, IR microspectrom-
eters equipped with multi detector arrays have paved the way to
minimize problems associatedwith tissuemicroheterogeneity and
data acquisition time, an essential prerequisite for future studies.
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